Skip to main navigation Skip to search Skip to main content

CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol

  • CONCEPTT Collaborative Group
  • Mt Sinai Hospital
  • University of Toronto/Lunenfeld-Tanenbaum Research Institute
  • University of Toronto Faculty of Medicine
  • Sunnybrook Health Sciences Centre
  • Sunnybrook Research Institute
  • Hospital de la Santa Creu I
  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina
  • Univ. of Calgary
  • Rabin Medical Center Israel
  • University of Ottawa
  • Jaeb Center for Health Research
  • St. Joseph Health Care
  • St. Joseph's Health Centre
  • Toronto General Hospital
  • Cambridge University Hospitals NHS Foundation Trust
  • University of East Anglia, Norwich Medical School
  • King's College Hospital
  • Niguarda ca' Granda Hospital
  • McMaster University
  • Queen’s University
  • Diabetes Center
  • Ipswich Hospital NHS Trust
  • Norfolk and Norwich University Hospitals NHS Foundation Trust
  • Guys and St Thomas' NHS Foundation Trust
  • St. Michael's Hospital, Toronto
  • Leeds Teaching Hospitals NHS Trust
  • Galway University Hospital
  • University Hospital of South Manchester
  • Royal Victoria Infirmary
  • South Tees Hospitals NHS Foundation Trust
  • Southampton General Hospital
  • Queen's Medical Centre
  • Sheffield Teaching Hospitals NHS Foundation Trust
  • Grampian Diabetes Centre
  • Royal Infirmary of Edinburgh
  • Glasgow Royal Infirmary
  • Centre hospitalier universitaire de Québec
  • Centre Hospitalier de Université de Montréal
  • Izaak Walton Killam Health Sciences Centre (IWK)
  • Royal University Hospital
  • Russells Hall Hospital
  • The Centre for Mother, Infant and Child Research (CMICR)

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

41 Citations (Scopus)

Abstract

Background: Women with type 1 diabetes strive for optimal glycemic control before and during pregnancy to avoid adverse obstetric and perinatal outcomes. For most women, optimal glycemic control is challenging to achieve and maintain. The aim of this study is to determine whether the use of real-time continuous glucose monitoring (RT-CGM) will improve glycemic control in women with type 1 diabetes who are pregnant or planning pregnancy. Methods/design: A multi-center, open label, randomized, controlled trial of women with type 1 diabetes who are either planning pregnancy with an HbA1c of 7.0 % to ≤10.0 % (53 to ≤ 86 mmol/mol) or are in early pregnancy (<13 weeks 6 days) with an HbA1c of 6.5 % to ≤10.0 % (48 to ≤ 86 mmol/mol). Participants will be randomized to either RT-CGM alongside conventional intermittent home glucose monitoring (HGM), or HGM alone. Eligible women will wear a CGM which does not display the glucose result for 6 days during the run-in phase. To be eligible for randomization, a minimum of 4 HGM measurements per day and a minimum of 96 hours total with 24 hours overnight (11 pm-7 am) of CGM glucose values are required. Those meeting these criteria are randomized to RT- CGM or HGM. A total of 324 women will be recruited (110 planning pregnancy, 214 pregnant). This takes into account 15 and 20 % attrition rates for the planning pregnancy and pregnant cohorts and will detect a clinically relevant 0.5 % difference between groups at 90 % power with 5 % significance. Randomization will stratify for type of insulin treatment (pump or multiple daily injections) and baseline HbA1c. Analyses will be performed according to intention to treat. The primary outcome is the change in glycemic control as measured by HbA1c from baseline to 24 weeks or conception in women planning pregnancy, and from baseline to 34 weeks gestation during pregnancy. Secondary outcomes include maternal hypoglycemia, CGM time in, above and below target (3.5-7.8 mmol/l), glucose variability measures, maternal and neonatal outcomes. Discussion: This will be the first international multicenter randomized controlled trial to evaluate the impact of RT- CGM before and during pregnancy in women with type 1 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT01788527Registration Date: December 19, 2012.

Original languageEnglish
Article number167
JournalBMC Pregnancy and Childbirth
Volume16
Issue number1
DOIs
Publication statusPublished - 18 Jul 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Continuous glucose monitoring
  • Diabetes mellitus type 1
  • Preconception
  • Pregnancy
  • Randomized controlled trial

Fingerprint

Dive into the research topics of 'CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol'. Together they form a unique fingerprint.

Cite this